<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04554004</url>
  </required_header>
  <id_info>
    <org_study_id>2020C03018</org_study_id>
    <nct_id>NCT04554004</nct_id>
  </id_info>
  <brief_title>A Non-invasive Index of Microciculatory Resistance</brief_title>
  <official_title>A Clinical Trial for CT Myocardial Perfusion Based Non-invasive Index of Microciculatory Resistance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First People's Hospital of Hangzhou</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First People's Hospital of Hangzhou</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Coronary artery microvascular disease (CMVD) lacks reliable and non-invasive quantitative&#xD;
      diagnosis methods. Improving coronary microcirculation has become one of the main goals of&#xD;
      coronary heart disease treatment. In this study, by establishing the key influencing factors&#xD;
      of myocardial microcirculation perfusion, an accurate three-dimensional reconstruction method&#xD;
      of coronary artery was established, and a non-invasive coronary microcirculation resistance&#xD;
      index (CT-IMR) calculation method based on computational fluid method mechanics was&#xD;
      established. At the same time, a phase I single-center clinical verification and a&#xD;
      multi-center clinical verification of the non-invasive coronary microcirculation function&#xD;
      precision assessment system were carried out, and a non-invasive coronary microcirculation&#xD;
      detection system and technology were established.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2022</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>sensitivity and specificity</measure>
    <time_frame>up to 12 months</time_frame>
    <description>The sensitivity and specificity of CT-IMR in the diagnosis of microcirculation dysfunction were studied.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>diagnostic</measure>
    <time_frame>up to 12 months</time_frame>
    <description>To study the diagnostic coincidence rate, positive predictive value and negative predictive value of CT-IMR in the diagnosis of microcirculation dysfunction.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">295</enrollment>
  <condition>Coronary Microvascular Disease</condition>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Study group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All consecutive patients undergoing outine CT angiography and dynamic CT-myocardial perfusion imaging(MPI) will be potentially eligible for inclusion in the trial. Assessment of coronary stenosis severity using invasive fractional flow reserve (FFR) and the status of myocardial microcirculation perfusion including coronary flow reserve (CFR) and index of microvascular resistance (IMR) will be performed as part of invasive coronary angiography(CAG).</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>CCTA, CT-MPI, DSA, FFR</intervention_name>
    <description>The patients who enrolled the study will undergo coronary CT angiography(CCTA), dynamic CT-MPI, invasive coronary angiography and invasive computation of fractional flow reserve (FFR)</description>
    <arm_group_label>Study group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject must be older than 18 years&#xD;
&#xD;
          -  Written informed consent available&#xD;
&#xD;
          -  Subject is indicated for invasive coronary angiography&#xD;
&#xD;
          -  Subject need to be taken within 30 days after enrolment&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous PCI or CABG&#xD;
&#xD;
          -  Subject is not eligible for measuring IMR&#xD;
&#xD;
          -  Complicated complex congenital heart disease&#xD;
&#xD;
          -  Artificial pacemaker or internal defibrillator leads implanted&#xD;
&#xD;
          -  Implanted artificial heart valve&#xD;
&#xD;
          -  Severe arrhythmia including complete AV block, ventricular arrhythmia&#xD;
&#xD;
          -  Impaired chronic renal function (serum creatinine&gt;1.5ULN)&#xD;
&#xD;
          -  Allergic to iodine&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Body mass index &gt;35 kg/m2&#xD;
&#xD;
          -  Left ventricle is markedly thickened&#xD;
&#xD;
          -  Needs for emergency procedures&#xD;
&#xD;
          -  Severe distortion of in the blood vessel&#xD;
&#xD;
          -  Unstable haemodynamics including abrupt chest pain cardiogenic shock, unstable blood&#xD;
             pressure (systolic &lt; 90mmHg), severe congestive heart failure or pulmonary edema&#xD;
&#xD;
          -  Life-threatening diseases (life expectancy &lt; 2 months)&#xD;
&#xD;
          -  Tako Tsubo syndrome (TTS)&#xD;
&#xD;
          -  Others who are inappropriate subject judged by clinician&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Beibei Gao</last_name>
    <phone>8615858114771</phone>
    <email>beier05@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>First People's Hospital of Hangzhou</name>
      <address>
        <city>Hanzhou</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <contact>
      <last_name>Xi Lv</last_name>
      <phone>0571-56007418</phone>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>September 8, 2020</study_first_submitted>
  <study_first_submitted_qc>September 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 18, 2020</study_first_posted>
  <last_update_submitted>July 28, 2021</last_update_submitted>
  <last_update_submitted_qc>July 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>First People's Hospital of Hangzhou</investigator_affiliation>
    <investigator_full_name>Jinyu Huang</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Microvascular Angina</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual participant data that underlie the results reported in this article after deidentification (text, table, figures, and appendices).</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>When will data be available (start and end dates)?Beginning 3 months. No end data.</ipd_time_frame>
    <ipd_access_criteria>Proposals should be directed to zdsyhjy0902@zju.edu.cn. To gain access, data requestors will need to sign a data access agreement.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

